EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds

Rubina Roy, Diwakar Kumar, Pallab Bhattacharya, Anupom Borah

Neurochemistry International · 2024

DOI: 10.1016/j.neuint.2024.105803 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2024. Verfasst von Rubina Roy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science & Bioinformatics, Assam University, Silchar, 788011, Assam, India. Hauptthemen laut MEDLINE: Parkinson Disease, Toll-Like Receptor 4, Lipopolysaccharides, Dysbiosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of the world's second leading neurodegenerative disorder Parkinson's disease (PD) is well known while its pathogenesis is still a topical issue to explore. Clinical and experimental reports suggest the prevalence of disturbed gut microflora in PD subjects, with an abundance of especially Gram-negative bacteria. The endotoxin lipopolysaccharide (LPS) released from the outer cell layer of these bacteria interacts with the toll-like receptor 4 (TLR4) present on the macrophages and it stimulates the downstream inflammatory cascade in both the gut and brain. Recent research also suggests a positive correlation between LPS, alpha-synuclein, and TLR4 levels, which indicates the contribution of a parallel LPS-alpha-synuclein-TLR4 axis in stimulating inflammation and neurodegeneration in the gut and brain, establishing a body-first type of PD. However, owing to the novelty of this paradigm, further investigation is mandatory. Modulating LPS biosynthesis and LPS-TLR4 interaction can ameliorate gut dysbiosis and PD. Several synthetic LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase; LPS-synthesizing enzyme) inhibitors and TLR4 antagonists are reported to show beneficial effects including neuroprotection in PD models, however, are not devoid of side effects. Plant-derived compounds have been long documented for their benefits as nutraceuticals and thus to search for effective, safer, and multitarget therapeutics, the present study focused on summarizing the evidence reporting the potential of phyto-compounds as LpxC inhibitors and TLR4 antagonists. Studies demonstrating the dual potential of phyto-compounds as the modulators of LpxC and TLR4 have not yet been reported. Also, very few preliminary studies have reported LpxC inhibition by phyto-compounds. Nevertheless, remarkable neuroprotection along with TLR4 antagonism has been shown by curcumin and juglanin in PD models. The present review thus provides a wide look at the research progressed to date in discovering phyto-compounds that can serve as LpxC inhibitors and TLR4 antagonists. The study further recommends the need for expanding the search for potential candidates that can render dual protection by inhibiting both the biosynthesis and TLR4 interaction of LPS. Such multitarget therapeutic intervention is believed to bring fruitful yields in countering gut dysbiosis, neuroinflammation, and dopaminergic neuron damage in PD patients through a single treatment paradigm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseToll-Like Receptor 4LipopolysaccharidesDysbiosisGastrointestinal MicrobiomeHumansAnimalsPhytochemicals

Stichwörter der Autor:innen

Dopaminergic neurodegenerationGram-negative bacteriaNeuroinflammationNutraceuticalsPro-inflammatory cytokines

Substanzen

Toll-Like Receptor 4LipopolysaccharidesPhytochemicalsTLR4 protein, human

Autor:innen und Institutionen

  • Department of Life Science & Bioinformatics, Assam University, Silchar, 788011, Assam, India.
  • Department of Microbiology, Assam University, Silchar, 788011, Assam, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, 382355, Gandhinagar, Gujarat, India.
  • Department of Life Science & Bioinformatics, Assam University, Silchar, 788011, Assam, India. Electronic address: anupomborahh@gmail.com.

Zitieren

APA

Roy, R., Kumar, D., Bhattacharya, P., & Borah, A. (2024). Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds. Neurochemistry International. https://doi.org/10.1016/j.neuint.2024.105803

Vancouver

Roy R, Kumar D, Bhattacharya P, Borah A. Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds. Neurochemistry International. 2024. doi:10.1016/j.neuint.2024.105803

BibTeX
@article{Roy2024,
  author = {Roy, Rubina and Kumar, Diwakar and Bhattacharya, Pallab and Borah, Anupom},
  title = {Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds},
  journal = {Neurochemistry International},
  year = {2024},
  doi = {10.1016/j.neuint.2024.105803}
}
Kostenlos starten →